Study to Assess Effect of Device and Formulation on Pharmacokinetics (PK) of AZD1402

NCT03921268 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: AZD1402

Sponsor

AstraZeneca